Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA

Michael O'Riordan

November 28, 2017

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

News Conference News AHA 2017

GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS

Yael L. Maxwell

November 14, 2017

News Daily News

Statins and Diabetes: Causal Link Reinforced in New Analysis

Michael O'Riordan

October 25, 2017

News Daily News

Switching to E-Cigarettes From Tobacco Could Drastically Curb Premature Death

Caitlin E. Cox

October 04, 2017

News Daily News

FDA Warns of Rising Endoleak Rates After Endovascular Aneurysm Repair

L.A. McKeown

October 02, 2017

News Daily News

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

Michael O'Riordan

August 17, 2017

News Daily News

Inferior Vena Cava Filter Use Fell After FDA Warning but Remains High

Todd Neale

July 12, 2017

News Daily News

Apixaban Recalled Following Complaints of Dose-Packaging Mismatch

Shelley Wood

June 13, 2017

News Industry News

AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle from That Lot

May 26, 2017

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

News Daily News

Absorb BVS Use Restricted in Europe

Michael O'Riordan

April 06, 2017

News Daily News

FDA: Class I Recall for Over 47,000 HeartStart MRx Monitor/Defibrillator Units

L.A. McKeown

March 24, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

Michael O'Riordan

March 18, 2017

News Daily News

FDA Warns Against Off-Label Use of Balloon Angioplasty to Treat Autonomic Dysfunction

Yael L. Maxwell

March 08, 2017

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

CME

Advertisement

Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS

Statins and Diabetes: Causal Link Reinforced in New Analysis

Switching to E-Cigarettes From Tobacco Could Drastically Curb Premature Death

FDA Warns of Rising Endoleak Rates After Endovascular Aneurysm Repair

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

Inferior Vena Cava Filter Use Fell After FDA Warning but Remains High

Apixaban Recalled Following Complaints of Dose-Packaging Mismatch

AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle from That Lot

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Absorb BVS Use Restricted in Europe

FDA: Class I Recall for Over 47,000 HeartStart MRx Monitor/Defibrillator Units

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

FDA Warns Against Off-Label Use of Balloon Angioplasty to Treat Autonomic Dysfunction

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

Changing Course with Anticoagulation in Secondary Prevention of CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content